MDSpire - Summary
Clinical Guidelines
Feature

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

A Keck Medicine of USC head and neck surgeon discusses circulating HPV DNA as a biomarker that could help make more individualized treatment decisions.

  • March 24, 2026

  • 5 min

Share

Circulating HPV DNA (HPV ctDNA) is being researched as a promising biomarker for oropharyngeal squamous cell carcinoma (OPSCC) related to human papillomavirus (HPV), which is increasingly prevalent. Daniel Kwon, MD, of the USC Head and Neck Center, discusses how this minimally invasive blood test can assist in monitoring treatment response and tailoring individual patient care by indicating the presence of cancer early. While further validation is required, these advances hold promise for personalizing management strategies for throat cancer patients.

Original Source(s)

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

  • March 24, 2026

Related Content

Platelet-Rich Plasma Reduces Pain After Tonsillectomy

Randomized trial shows reduced postoperative pain and faster mucosal healing without increased bleeding risk

Opioid Prescribing Trends After Guidelines

Large US data set tracks postoperative analgesic use over a decade.

CRS Trial Reveals Surgery Divide

MACRO qualitative study explores why patients differ in attitudes toward endoscopic sinus surgery.